News

-2022-

California plans to make its own insulin and sell it super-cheap. Really. An Arm and a Leg (podcast). https://armandalegshow.com/episode/california-making-insulin/

Profits of the largest pharmaceutical companies grow 41% in the pandemic. [Lucro das maiores farmacêuticas cresce 41% na pandemia]. Poder360. https://www.poder360.com.br/coronavirus/lucro-das-maiores-farmaceuticas-cresce-41-na-pandemia/

Extended interview: https://www.poder360.com.br/coronavirus/farmaceuticas-podiam-cobrar-menos-diz-pesquisadora-de-harvard/

How Many Variants And Deaths Are We Willing To Accept, Before We Protect The Whole World? Forbes. https://www.forbes.com/sites/madhukarpai/2022/07/12/how-many-variants-and-deaths-are-we-willing-to-accept-before-we-protect-the-whole-world/?sh=45e316452233

W.T.O. countries agree to a limited relaxing of patent protections on coronavirus vaccines. The New York Times. https://www.nytimes.com/2022/06/17/business/wto-covid-vaccine-patent.html

Behind Pfizer's new not-for-profit deal on patented vaccines and drugs. Devex. https://www.devex.com/news/behind-pfizer-s-new-not-for-profit-deal-on-patented-vaccines-and-drugs-103323

African clinical trial denied access to key COVID drug Paxlovid. Nature. https://www.nature.com/articles/d41586-022-00919-5

RAI (Radiotelevisione italiana, national Italian broadcaster). Report. https://www.raiplay.it/video/2022/01/La-vigile-attesa---Report-31012022-667606d9-ff1e-4323-9add-0669ab47e532.html?wt_mc=2.www.wzp.raiplay_dati

Paxlovid e Molnupiravir, pillola anti-Covid: il ricatto delle case farmaceutiche ai sistemi sanitari. [Paxlovid and Molnupiravir, anti-Covid pill: the blackmail of pharmaceutical companies to health systems]. Corriere della Sera.
https://www.corriere.it/dataroom-milena-gabanelli/paxlovid-molnupiravir-pillola-anti-covid-ricatto-case-farmaceutiche-sistemi-sanitari-tutti-guadagni/2fdb32ba-97d7-11ec-97aa-535db4de4386-va.shtml

 

-2021-

Merck’s Covid-19 pill may be a game-changer, but questions are already being raised about cost. STAT. https://www.statnews.com/pharmalot/2021/10/04/covid19-merck-molnupiravir-ridgeback-patents/

Merck Sells Federally Financed Covid Pill to U.S. for 40 Times What It Costs to Make. The Intercept. https://theintercept.com/2021/10/05/covid-pill-drug-pricing-merck-ridgeback/

Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines? The New York Times. https://www.nytimes.com/2021/10/17/health/covid-treatment-access-molnupiravir.html

Covid pill makers accused of selling drug to US at 40 times what it costs to make despite govt funding. Independent. https://www.independent.co.uk/news/world/americas/us-merck-covid-pill-cost-b1933100.html

Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill. Fortune India. https://www.fortuneindia.com/enterprise/why-mercks-new-covid-19-drug-banks-on-india-2/105949

Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill. Health Policy Watch. https://healthpolicy-watch.org/generic-companies-are-ready-to-make-mercks-covid-19-pill/

'Entirely unsurprising': Merck slammed for 4,000% markup of taxpayer-funded COVID-19 drug. Salon.
https://www.salon.com/2021/10/07/entirely-unsurprising-merck-slammed-for-4000-markup-of-taxpayer-funded-19_partner/

KNX In Depth, (live LA current affairs radio show).

Buyers clamor for Merck's COVID-19 antiviral molnupiravir, but pricing is already controversial. Fierce Pharma.
https://www.fiercepharma.com/pharma/amid-controversy-over-its-price-rush-to-secure-merck-and-ridgeback-s-covid-19-drug

WHO-led programme aims to buy antiviral COVID-19 pills for $10 -document. Reuters. https://www.reuters.com/business/healthcare-pharmaceuticals/exclusive-who-led-programme-aims-buy-antiviral-covid-19-pills-10-document-2021-10-19/

 

-2020-

40+ progressive public sector organizations compiled a directory of suggested hires to the Biden Transition team. I was honored to be included with 12 other prescription drug policy leaders. https://transitionnames.progressivechangeinstitute.com

 

States are trying to cap the price of insulin. NBC. Pharmaceutical companies are pushing back. https://www.nbcnews.com/news/us-news/states-are-trying-cap-price-insulin-pharmaceutical-companies-are-pushing-n1236766

La insulina podría ser más barata sin que las farmacéuticas pierdan ganancias, según studio. El espectador. https://www.elespectador.com/salud/la-insulina-podria-ser-mas-barata-sin-que-las-farmaceuticas-pierdan-ganancias-segun-estudio-article-815051/

Elizabeth Warren’s 2020 healthcare campaign policy paper. https://medium.com/@teamwarren/my-first-term-plan-for-reducing-health-care-costs-in-america-and-transitioning-to-medicare-for-all-8d45dd993872

 

-2019-

 

Why Insulin Defies The Normal Rules Of Economics And Keeps Getting More Expensive. WBUR, 2019.  https://www.wbur.org/news/2019/06/25/why-insulin-defies-the-normal-rules-of-economics-and-keeps-getting-more-expensive.

 

Why would the government make its own drugs? New Statesman. https://www.newstatesman.com/politics/health/2019/10/why-would-government-make-its-own-drugs

Biologics and Biosimilars: Background and Key Issues. Congressional Research Service. https://sgp.fas.org/crs/misc/R44620.pdf

 

-2018-

Insulin prices could be much lower and drug makers would still make healthy profits. STAT. https://www.statnews.com/pharmalot/2018/09/25/insulin-prices-profits-diabetes/

 

-2017-

EU starts investigation of Aspen's cancer drug pricing. PmLiVE.
https://www.pmlive.com/pharma_news/eu_starts_investigation_of_aspens_cancer_drug_pricing_1192899

Drugs firms are accused of putting cancer patients at risk over price hikes. The Guardian. https://www.theguardian.com/society/2017/jan/28/nhs-drug-firms-cancer-patients-at-risk-prices-inflated

Cancer drugs price rise 'costing NHS millions'. BBC. www.bbc.com/news/health-38769625

Price hikes for some generic cancer drugs in the UK have skyrocketed. STAT. https://www.statnews.com/pharmalot/2017/01/30/cancer-generics-drug-prices/

The drug rebellion fighting big pharma to save the NHS millions. https://www.newscientist.com/article/mg23431281-100-big-pharma-makes-a-killing-off-deadly-diseases-what-can-stop-them/